• Oxford Genetics extends its CRISPR Gene Editing Technology License Agreement from ERS Genomics to support its growth internationally
  • Oxford Genetics signs major supply and licensing agreement for CRISPR engineered mammalian cell lines
  • Oxford Genetics Announces New Online Customer Portal for Custom Research Services
  • Influenza, the difficulty of producing effective vaccines, and recent innovation in flu vaccines
  • DNA origami: from novelty item to novel applications
  • Genome Editing: One Small Needle for Brian, One Giant Injection For Gene Therapy
  • Gene and Cell Therapy Phacilitate
Subscribe to our newsletter